Targeted Mobilisation of Endogenous Endothelial Progenitor Cells — an Alternate Approach to Allogeneic Therapy for Ischaemic Cardiovasular Disease? Karla M. O’NeillDavid J. Grieve Invited Editorial 03 May 2023 Pages: 839 - 841
Trimetazidine to Reduce Myocardial Fibrosis—Competing Interests with SGLT2 Inhibitors? Tyler B. MoranMasafumi KitakazeYochai Birnbaum Editorial 13 September 2023 Pages: 843 - 844
Reply to the Letter to the Editor Titled “The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?” by Han et al Senay AkinHaydar A. Demirel Letter to the Editor 20 August 2022 Pages: 845 - 846
The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe? Qian-Feng HanJia-Hui LiuDe-Gang Mo Letter to the Editor 24 August 2022 Pages: 847 - 848
CXCR7 Agonist TC14012 Improves Angiogenic Function of Endothelial Progenitor Cells via Activating Akt/eNOS Pathway and Promotes Ischemic Angiogenesis in Diabetic Limb Ischemia Kai WangShiyue SunYi Tan Original Article 26 April 2022 Pages: 849 - 863
Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor Helmut Raphael LiederMaria TsoumaniPetra Kleinbongard Original Article Open access 21 May 2022 Pages: 865 - 876
CircPCNX Promotes PDGF-BB-Induced Proliferation and Migration of Human Aortic Vascular Smooth Muscle Cells Through Regulating miR-1278/DNMT1 Axis Wenbin MaDongmei WeiBen Zhang Original Article 07 June 2022 Pages: 877 - 889
Mesenchymal Stem Cell–Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes Hang YuYuxiang PanHaibo Chen Original Article 11 May 2022 Pages: 891 - 904
Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective Xiaoyu XiXin WangQuanming Zhao Original Article 25 April 2022 Pages: 905 - 916
Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore Xin Qin SohDoreen Su-Yin TanEric Chun Yong Chan Original Article 14 May 2022 Pages: 917 - 925
Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials Shuai YangWen ShenQing-Hua Wu Original Article 05 May 2022 Pages: 927 - 940
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI Antonio J. Vallejo-VazSarah BrayOn behalf of the DA VINCI Study Investigators Original Article Open access 14 May 2022 Pages: 941 - 953
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients Noha M. El-khodaryAsser I. GhoneimEman M. El-touny Original Article Open access 10 May 2022 Pages: 955 - 964
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study Sunao KojimaKazuaki Uchiyamaon behalf of the Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy (FREED) investigators Original Article 01 June 2022 Pages: 965 - 974
Antiplatelet Therapy in End-stage Renal Disease Patients on Maintenance Dialysis: a State-of-the-art Review Pietro Igor PonchiaRaheel AhmedMohammad Alkhalil Review Article 22 July 2022 Pages: 975 - 987
SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fraction Juan Antonio Requena-IbanezCarlos G. Santos-GallegoJuan J. Badimon Review Article 03 August 2022 Pages: 989 - 996
Mechanobiology of the endothelium in vascular health and disease: in vitro shear stress models Molly L. JacksonAndrew Richard BondSarah Jane George Invited Review Article Open access 03 October 2022 Pages: 997 - 1010
Considerations for Left Atrial Appendage Occlusion During Cardiac Surgery Christopher B. SylvesterVivek PatelGabriel Loor Invited Review Article 23 December 2022 Pages: 1011 - 1019
Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts Emily Davis AlexanderJessa L. AldridgeChad R. Frasier Short Communication 30 April 2022 Pages: 1021 - 1026
Long-term Dexamethasone Treatment Increases Cardiac Galectin-3 Levels Senay AkinEsra Gucuk-IpekHaydar A. Demirel Short Communication 13 May 2022 Pages: 1027 - 1029
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial Raffaele PiccoloMarisa AvvedimentoGiovanni Esposito Trial Designs 20 January 2022 Pages: 1031 - 1038